Laparoscopic Gastric Bypass With the Total Wrapping of the Fundus of Gastric Excluded Part for Treating Obesity and GERD
Primary Purpose
Obesity, GERD
Status
Active
Phase
Not Applicable
Locations
Kazakhstan
Study Type
Interventional
Intervention
Antireflux laparoscopic one anastomosis gastric bypass
Standard laparoscopic one anastomosis gastric bypass
Sponsored by
About this trial
This is an interventional treatment trial for Obesity focused on measuring Obesity, GERD, Gastric bypass, Fundoplication
Eligibility Criteria
Inclusion Criteria:
- BMI from 30 to 50 kg / m2.
- Gastroesophageal reflux diseases
- The person is generally fit for anesthesia (ASA grading 1-2) and surgery.
- The person commits to the need for long-term follow-up.
Exclusion Criteria:
- BMI less than 30 kg / m2 and more than 50 kg / m2.
- Prosthetic (mesh) hiatal herniorrhaphy or large hiatal hernia;
- Esophageal shortening
- Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis
- History of surgery on the stomach or esophagus
- Less than 18 or more than 60 years of age
- Not fit for bariatric surgery
- Psychiatric illness
- Patients unwilling or unable to provide informed consent
Sites / Locations
- Oral Ospanov
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Antireflux OAGB group
Standard OAGB group
Arm Description
Antireflux laparoscopic one anastomosis gastric bypass with suture cruroplasty and the total wrapping of the fundus of the gastric excluded part.
laparoscopic one anastomosis gastric bypass with only suture cruroplasty.
Outcomes
Primary Outcome Measures
Change of body mass index
The measure is assessing a change of body mass index. Weight (kg) and height (cm) will be combined with the report of measurement by body mass index (BMI) kg/m2.
Change of GERD symptoms (GERD-HRQL)
Success; ≥50% improvement in the baseline GERD-HRQL score Failure; <50% improvement in the baseline GERD-HRQL score at 12,24, 36 months.
Secondary Outcome Measures
Full Information
NCT ID
NCT04828733
First Posted
March 30, 2021
Last Updated
October 12, 2022
Sponsor
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
1. Study Identification
Unique Protocol Identification Number
NCT04828733
Brief Title
Laparoscopic Gastric Bypass With the Total Wrapping of the Fundus of Gastric Excluded Part for Treating Obesity and GERD
Official Title
A Randomized Controlled Trial of Laparoscopic One Anastomosis Gastric Bypass (OAGB) With the Cruroraphy and Total Wrapping of the Fundus of Gastric Excluded Part Versus OAGB With Only Hiatus Cruroraphy for Treating Morbid Obesity and GERD
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 29, 2021 (Actual)
Primary Completion Date
April 5, 2024 (Anticipated)
Study Completion Date
May 10, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background and study aims:
Currently, one anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is a common bariatric procedure.
Obesity and gastroesophageal reflux disease are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients. In these cases, most often, hiatus cruroraphy is performed, and less often fundoplication using the fundus of the excluded part of the stomach. We hypothesize that total fundoplication can not only treat GERD but also prevent the return of weight like a banded gastric bypass.
The aim study is to compare bariatric and antireflux results after OAGB/MGB plus suture cruroplasty (SCP) with and without total fundoplication.
Methods: Adult participants (n=100) are randomly allocated to one of two groups:
Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty (OAGB + SCP + TF group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=50) undergo the laparoscopic one anastomosis gastric bypass with only suture cruroplasty (OAGB + SCP group). All patients are then followed up 12, 24, 36 months after surgery where record the changing body mass index and change of GERD symptoms (GERD-HRQL).
Detailed Description
One anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is gaining popularity as a primary surgical treatment for morbid obesity. The total fundoplication is the gold standard for treating GERD. Morbid obesity and GERD require simultaneous surgical treatment. We hypothesize that total fundoplication can not only treat GERD but also prevent the return of weight like a banded gastric bypass.
The aim study is to compare bariatric and antireflux results after OAGB/MGB plus suture cruroplasty (SCP) with and without total fundoplication.
Adult participants (n=100) are randomly allocated to one of two groups:
Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty (OAGB + SCP + TF group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=50) undergo the laparoscopic one anastomosis gastric bypass with only suture cruroplasty (OAGB + SCP group). All patients are then followed up 12, 24, 36 months after surgery where record the changing body mass index and change of GERD symptoms (GERD-HRQL).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, GERD
Keywords
Obesity, GERD, Gastric bypass, Fundoplication
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Antireflux OAGB group
Arm Type
Experimental
Arm Description
Antireflux laparoscopic one anastomosis gastric bypass with suture cruroplasty and the total wrapping of the fundus of the gastric excluded part.
Arm Title
Standard OAGB group
Arm Type
Active Comparator
Arm Description
laparoscopic one anastomosis gastric bypass with only suture cruroplasty.
Intervention Type
Procedure
Intervention Name(s)
Antireflux laparoscopic one anastomosis gastric bypass
Intervention Description
Laparoscopic gastric bypass with suture cruroplasty and total wrapping of the fundus of gastric excluded part.
Intervention Type
Procedure
Intervention Name(s)
Standard laparoscopic one anastomosis gastric bypass
Intervention Description
laparoscopic gastric bypass with only suture cruroplasty. Not used fundoplication.
Primary Outcome Measure Information:
Title
Change of body mass index
Description
The measure is assessing a change of body mass index. Weight (kg) and height (cm) will be combined with the report of measurement by body mass index (BMI) kg/m2.
Time Frame
Baseline, at 12, 24, 36 months after surgery
Title
Change of GERD symptoms (GERD-HRQL)
Description
Success; ≥50% improvement in the baseline GERD-HRQL score Failure; <50% improvement in the baseline GERD-HRQL score at 12,24, 36 months.
Time Frame
12, 24, 36 months after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
BMI from 30 to 50 kg / m2.
Gastroesophageal reflux diseases
The person is generally fit for anesthesia (ASA grading 1-2) and surgery.
The person commits to the need for long-term follow-up.
Exclusion Criteria:
BMI less than 30 kg / m2 and more than 50 kg / m2.
Prosthetic (mesh) hiatal herniorrhaphy or large hiatal hernia;
Esophageal shortening
Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis
History of surgery on the stomach or esophagus
Less than 18 or more than 60 years of age
Not fit for bariatric surgery
Psychiatric illness
Patients unwilling or unable to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oral Ospanov, Professor
Organizational Affiliation
President of Society of Bariatric and Metabolic Surgeons of Kazakhstan" (SBMSK)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oral Ospanov
City
Astana
ZIP/Postal Code
020000
Country
Kazakhstan
12. IPD Sharing Statement
Learn more about this trial
Laparoscopic Gastric Bypass With the Total Wrapping of the Fundus of Gastric Excluded Part for Treating Obesity and GERD
We'll reach out to this number within 24 hrs